Jeffrey Shuren

Jeffery Shuren

Jeffrey Shuren was the Director of the Center for Devices and Radiological Health (CDRH) at the United States Food and Drug Administration (FDA) from September 2009 to July 2024.[1][2]

Shuren was responsible for the development of Medicare national coverage determinations for drugs, biologics, and non-implantable devices, while director of the Division of Items and Devices, Coverage and Analysis Group at the Centers for Medicare and Medicaid Services.[1] His long-term position as director of CDRH was one of tremendous responsibility and importance; according to the New York Times, "Dr. Shuren led an office with about 2,500 staff members and a budget of about $790 million. He oversaw thousands of devices, ranging from tests to detect blood-lead levels to IV infusion pumps to ventilators."[2]

Jeffrey Shuren announced his plans to retire from the agency in July 2024.[2]

  1. ^ a b Cite error: The named reference FDA was invoked but never defined (see the help page).
  2. ^ a b c Jewett, Christina (August 20, 2024). "He Regulated Medical Devices. His Wife Represented Their Makers". nytimes.com. The New York Times. Retrieved August 22, 2024.